Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Watch the Recording What Youll Learn Current payer perspectives on GLP-1 coverage for obesity treatment and type 2 diabetes management Emerging affordability thresholds and price sensitivity among plans Strategies for addressing off-label type 2 diabetes GLP-1 use and its financial impact Approaches to prior authorization protocols and BMI requirements for obesity GLP-1s The role of weight management vendors in comprehensive obesity GLP-1 coverage strategies Market insights on compounded GLP-1 products and their place in benefit design Attendees will gain actionable strategies and insights to optimize their pharmacy benefit design for these high-impact medications in 2025 and beyond
Obesity- and aging-induced excess of central transforming growth factor-beta potentiates diabetic development via an RNA stress response
oleifera showed anti-microbial activity against Gram-positive bacteria [74]
Many of our White Plains patients come to us through word of mouth and stay because they feel genuinely cared for
See the end of this Medication Guide for a complete list of ingredients in SYMLIN
